INTRODUCTION
Natural killer (NK) cell neoplasms are a group of rare but highly malignant tumors with a broad spectrum of morphologic, immunophenotypes and clinical features. The WHO classification of NK cell neoplasms encompasses 3 distinct entities: 1) aggressive NK cell leukemia, 2) extranodal NK/Tcell lymphoma, nasal type [1] , and 3) blastic NK cell lymphoma [2] . NK cell tumors are prevalent in Asia and Central and South America. NK cells were originally described as large granular lymphocytes with natural cytotoxicity against tumor cells. NK cells were later recognized as a separate lymphocyte lineage [3] . NK cells represent a lineage of non-T lymphocytes and non-B lymphocytes that mediate a major histocompatibility complex-nonrestricted cytotoxicity against tumor cells and bacterial or viral infected cells [4] . They constitute 10 to 15% of human peripheral blood lymphocytes and express CD2, cytoplasmic CD3e and 
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Natural killer (NK) cell neoplasms are a group of rare but highly malignant tumors. We report here one case of NK cell leukemia. A 54-yr-old woman presented with a 2-month history of progressive left neck mass. Based on the positive result of tissue PCR for Mycobacterium tuberculosis, she was at first diagnosed with tuberculous lymphadenopathy. After two weeks, she developed generalized lymphadenopathy, hepatosplenomegaly, fever and anemia. Subsequent evaluation was performed including bone marrow aspiration and biopsy. Peripheral blood smear showed leukoerythroblastic features with 31% blasts. Bone marrow was packed with agranular blastoid cells, which were periodic acid-Schiff (PAS) positive and myeloperoxidase (MPO) negative. Immunophenotyping showed that these cells were positive for CD45 and HLA-DR, whereas negative for CD3, CD5, CD7, CD10, CD13, CD14, CD19, CD20, CD22, CD33, CD34, and CD61. Because of the absence of the markers of T-cell, B-cell, and myeloid lineage-specific antigens, we added CD16/56 for the immunophenotyping and the blasts were positive (94%). The tumor cells of biopsied lymph node were only positive for CD56, consistent with NK cell lymphoma. Epstein-Barr virus (EBV) was not detected by RNA in situ hybridization. Culture for M. tuberculosis was negative. Thus this patient was diagnosed with blastic NK cell lymphoma/leukemia involving bone marrow and lymph node. (Korean J Lab Med 2009; 29:194-8) CD56 without T cell receptor (TCR) gene rearrangement [5, 6] . The CD56 antigen is regarded as a marker of NK cell leukemia because it is consistently expressed although not specific for NK cells [7] . The etiology of NK cell neoplasm is not well understood but is considered to be strongly associated with Epstein-Barr virus (EBV). We report here the clinical, laboratory, and immunophenotypic findings of NK cell leukemia of a 54-yr-old woman. (Fig. 2) . The cytochemistry was positive only for periodic acid-Schiff (PAS) (Fig. 3) (Fig. 4) . The cytogenetic finding was 46, XX normal karyotype. With these findings, she was diagnosed with blastic NK cell lymphoma/leukemia involving bone marrow, and lymph node. For further management, she was transferred to a community cancer center. [8, 9] . In a previous study, tissue PCR was found to be highly sensi-tive (94.4%), although less specific (38.2%) [10, 11] . There can be problems in the PCR technique. PCR may be influenced by the processing technique. PCR may be false positive due to contamination. In addition, positive PCR results of M. tuberculosis have been reported from sarcoidosis lesions, which may not have clinical relevance [12] . In our case, Gram stain and AFB stain were negative. Culture was examined weekly for 8 weeks and there were no visible colonies. Therefore, this tissue-PCR result may be false positive.
CASE REPORT

DISCUSSION
NK cell tumors are a heterogeneous group of disorders. These are classified into three groups: 1) aggressive NK cell leukemia, 2) extranodal NK/T-cell lymphoma, nasal type [1] , and 3) blastic NK cell lymphoma [2] . Among these, extranodal NK/T-cell lymphoma, nasal type is the most common type and is characterized by extranodal presentation, pleomorphic cells with angioinvasion and angiodestruction, azurophillic granules, and a strong association with EBV. Extranodal NK/T-cell lymphomas are considered to originate from mature NK cells and express CD56, CD2, and cytoplasmic CD3ε , but not surface CD3, CD5, CD16 or CD57 [2, 7] . Imamura et al. characterized aggressive NK cell leukemia first as a catastrophic, systemic disease and more prevalent in Asians than in Caucasians [6] . It is highly malignant and rapidly progressive. Clinical features are fever, systemic symptoms, liver dysfunction, hepatosplenomegaly, and systemic lymphadenopathy. Cutaneous lesions are un- Chronic NK cell lymphocytosis is a chronic expansion of mature looking NK cells (≥600/μ L) in the peripheral blood for ≥6 months. This is characterized by a chronic, indolent course. In rare cases, the disease is transformed into aggressive NK cell leukemia [13] .
Precursor lymphoblastic lymphoma/leukemia (LBL) expressing NK-cell associated antigens is a rare entity [14] .
In a study by Sheibani et al., six tumors that expressed CD16
and CD57 in addition to terminal deoxynucleotidyl transferase (TdT), CD2, and CD4 were identified among 38 patients who were screened for LBL. These tumors, were grouped as "NK-LBL" [14] . Subsequently, CD56 has been recognized as a sensitive marker for NK cells. The patients frequently presented with leukemia and lymphadenopathy without skin involvement. These tumors were negative for EBV [12] .
Our case was diagnosed with blastic NK cell lymphoma/ leukemia. In our case, the leukemic cells expressed CD56 in the absence of the markers of T-cell, B-cell, and myeloid lineage-specific antigens. These cells involved bone marrow, peripheral blood and lymph node. There was no involvement of skin or nasal cavity. Morphologically, these cells were blasts rather than large granular lymphocytes. Intracytoplasmic azaurophilic granules were absent. EBV was negative. These findings are unusual in aggressive NK cell leukemia. Aggressive NK cell leukemia is associated with EBV, whereas blastic NK cell lymphoma is not related to EBV. Azurophilic granules in the cytoplasm are present in aggressive NK cell leukemia, whereas they are absent in blastic NK cell lymphoma. Consequently, this case was classified as blastic NK cell lymphoma/leukemia.
Although NK cell neoplasm is a very rare entity, clinicians should always recognize this disease. NK cell neoplasms show overlapping clinical and pathologic features with other lymphomas. When morphology of tumor cells is blastic, and immunophenotyping of these cells has no myeloid or lymphoid lineage specific markers, it is necessary to add NK cell specific marker for immunophenotyping. CD56 is not lineage-specific and can be expressed by other neoplasms.
However, specific markers for NK cells, such as CD161, CD-117, and CD94 [15] are not routinely tested in clinical hematology laboratory. These markers will be useful for clarifying blastic NK cell leukemia.
